Background: Fungal infection of the nail affects millions of people worldwide, and has an estimated prevalence of about 10% of the general population. Laboratory confirmation of fungal infection is currently accepted as a requirement before initiation of antifungal treatment in clinical practice.
Aim: To examine the rationale for systemic treatment in cases of clinical onychomycosis with negative results on fungal examination (potassium hydroxide test and fungal culture).
Methods: In total, 147 patients with suspected clinical toenail onychomycosis but with negative results on fungal examination underwent up to three consecutive fungal examinations of the affected nails. Patients who were negative after these examinations underwent a fourth set of investigations, including PCR.
Results: Of the 147 cases initially thought to be negative, 138 (94%) were rated as positive after up to four consecutive sets of laboratory mycological investigations including PCR. Trichophyton rubrum was by far the commonest dermatophyte cultured from all samples.
Conclusions: In the majority of cases of initially negative examinations, consecutive laboratory fungal tests will eventually produce positive results. These findings suggest that systemic antifungal treatment should be started in patients with suspected fungal infections, even if they have negative laboratory fungal examinations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2230.2011.04082.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Terbinafine in acrylic polymer for the treatment of onychomycosis in hemodialysis patients: a phase II clinical trial.
Front Med (Lausanne)
November 2024
Laboratory of Molecular Biology and Genetics, Health Sciences Postgraduate Program, São Francisco University, Bragança Paulista, Brazil.
Introduction: Onychomycosis is a nail infection caused by dermatophyte fungi, non-dermatophyte fungi, and yeast. Patients with chronic kidney disease on dialysis are part of the population that presents higher rates of this disease, mainly due to immunosuppression. Among patients with chronic kidney disease on dialysis, the treatment of onychomycosis is complex, mainly due to the limitations imposed by comorbidities.
View Article and Find Full Text PDF"Unveiling onychomycosis: Pathogenesis, diagnosis, and innovative treatment strategies".
Microb Pathog
January 2025
Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan. Electronic address:
Article Synopsis
- - Onychomycosis is a common fungal nail infection causing discoloration and detachment of nails, with increasing cases attributed to non-dermatophyte molds (NDMs) in warmer climates, alongside traditional dermatophytes.
- - Diagnosis is challenging due to high false-negative rates in standard methods, making histology and PCR more reliable, although they require careful handling to avoid contamination.
- - Treatment includes oral antifungals with better cure rates but more side effects, and topical options that are safer but less effective; ongoing research focuses on improving delivery methods and emphasizes the need for preventive measures to reduce reinfection rates.
Clinical inertia in onychomycosis treatment: results from the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
J Dermatol
January 2025
Sato Pharmaceutical Co., Ltd, Tokyo, Japan.
Article Synopsis
- Onychomycosis is a persistent fungal nail infection that can spread and negatively impact a person's ability to walk and their quality of life, making treatment crucial, especially through long-term topical therapies.
- A study revealed that many patients are unhappy with the effectiveness of their topical treatments—over half saw no clear improvement after more than two years—and most wished to explore different options, yet few discussed this with their doctors.
- There is a notable disconnect in communication between patients and dermatologists regarding treatment efficacy, leading to a lack of adjustments in therapy despite patient dissatisfaction, highlighting the need for better collaboration in managing onychomycosis.
Extended Use of Topical Efinaconazole Remains Safe and Can Provide Continuing Benefits for Dermatophyte Toenail Onychomycosis.
J Fungi (Basel)
August 2024
Mediprobe Research Inc., 645 Windermere Rd., London, ON N5X 2P1, Canada.
Article Synopsis
- Efinaconazole 10% is a topical treatment for onychomycosis (fungal nail infection) that has shown promising results in a 24-month study, indicating that longer treatment may enhance effectiveness.
- In a trial with 101 participants, those treated for 24 months had a mycological cure rate increase from 66.0% at 12 months to 71.7% at 24 months, alongside a rise in effective cure rates.
- Most side effects were mild and unrelated to systemic issues, suggesting that older patients and those with more severe infections can safely and effectively use the treatment without additional risks.
Monocentric evaluation of the Novaplex dermatophyte multiplex qPCR assay in the diagnosis of dermatophytoses.
J Clin Microbiol
October 2024
CHU Rennes, Laboratoire de parasitologie-mycologie, European ECMM Excellence Center in Medical Mycology, Centre National de Référence pour les mycoses et antifongiques-Laboratoire associé Aspergilloses chroniques, Rennes, France.
Article Synopsis
- Superficial fungal infections from dermatophytes are common and diagnosing them quickly is important for effective treatment, but traditional methods like fungal culture have drawbacks, including slow results and variable accuracy.
- This study tested the Novaplex dermatophyte assay (a type of real-time PCR) against standard mycological methods using 312 samples and found PCR had a high concordance rate of 87.2% compared to culture methods.
- While the Novaplex assay shows promise with high sensitivity (up to 100% for some targets) and specificity (96.6% for PCR), it cannot fully replace traditional methods since it doesn't detect all mold infections or identify specific dermatophyte species.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!